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ABSTRACT 
A glycosyltransferase, a1 ,3galactosyltransferase, catalyzes the terminal step in biosynthesis of 
Gala1 IPdal~1-4dlckAc-o (aGal), an oligosaccharide cell surface epitope. This epitope or antigenically 
similar epitopes are widely distributed among the different forms of life. Although abundant in most 
mammals, aGal is not normally found in catarrhine primates (Old World monkeys and apes, including 
humans), all of which produce anti-aGal antibodies from infancy onward. Natural selection favoring 
enhanced resistance to aGal-positive pathogens has been the primary reason offered to account for the 
loss of aGal in catarrhines. Here, we question the primacy of this immune defense hypothesis with results 
that elucidate the evolutionary history of GGTA1 gene a.nd pseudogene loci. One such locus, GGTA1P, a 
processed (intronless) pseudogene (PPG), is present in platyrrhines, i.e., New World monkeys, and 
catarrhines but not in prosimians. PPG arose in an early ancestor of anthropoids (catarrhines and 
platyrrhines), and GGTA 1 itself became an unprocessed pseudogene in the late catarrhine stem lineage. 
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Strong purifying selection, denoted by low nonsynonymous substitutions per nonsynonymous 
site/synonymous substitutions per synonymous site values, preserved GGTA 1 in noncatarrhine mammals, 
indicating that the functional gene product is subjected to considerable physiological constraint. Thus, we 
propose that a pattern of alternative and/or more beneficial glycosyltransferase activity had to first evolve in 
the stem catarrhines before GGTA 1 inactivation could occur. Enhanced defense against aGal-positive 
pathogens could then have accelerated the replacement of aGal-positive catarrhines by aGal-negative 
catarrhines. However, we emphasize that positively selected regulatory changes in sugar chain 
metabolism might well have contributed in a major way to catarrhine origins. 
Keywords: adaptive evolution, glycobiology, pseudogene 
The catarrhine primates (Old World monkeys and apes, including humans) are distinguished from other 
primates by a suite of biological characteristics among which are relatively long life spans, extended 
periods of growth and development, long generation times, large body sizes, atrophied vomeronasal 
organs but trichromatic vision, and increased en cephalization (1-1). Unearthing the genetic, epigenetic, 
environmental, and behavioral changes associated with the emergence of these features is a major goal of 
evolutionary primatologists. It is evident from the fossil record and molecular divergence estimates that 
many of the genetic changes associated with the emergence of catarrhines occurred between 40 and 25 
million years ago (mya) (§). Some of the genetic changes during this period of stem-catarrhine evolution 
drastically altered the prevalence of different cell surface sugar chains in tissues. In this article, we focus 
on elucidating the evolutionary history of the genetic locus, GGTA 1, that was involved in an especially 
enigmatic alteration, the loss of the cell-surface sugar chain epitope termed aGal (Gala1 ,3Gal ~1-4dlckAc­
R). The GGTA 1 locus encodes a particular glycosyltransferase, the Golgi transmembrane-bound a1,3 
galactosyltransferase (a1 ,3GT, EC 2.4.1.87) that catalyzes the terminal step in biosynthesis of the aGal 
epitope (f3). 
With the sole exception of catarrhines (I), the aGal epitope is expressed on the surface of cells in all 
mammalian species examined to date, including artiodactyls, carnivores, rodents, prosimians, and 
platyrrhines (New World monkeys) (I, §). The epitope is abundant on such different cells as those of the 
vascular system (a), the digestive mucosa (.!t,) and the vomeronasal sensory epithelium (10). The aGal-
negative catarrhines produce high titers of anti-aGal antibodies from infancy onward eLl). These antibodies 
are similar to the anti-A and anti-B isoagglutinins of humans who lack the A or B antigens of the ABH histo-
blood type oligosachharides. Because of the high titer of catarrhine anti-aGal antibodies, immediate 
(hyperacute) rejection occu rs when organs, tissues, or cells are transplanted from aGal-positive species to 
aGal-negative catarrhines (12). 
The molecular basis for aGal expression was established by the cloning of bovine (13), mouse (14), and 
porcine (lQ) GGTA 1 cDNA, by examination of the mouse (1§) and porcine (J 7-20) GGTA 1 genomic 
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organiiation, and by production of GGTA 1 knockout mice (21) and pigs (22). Insight into why catarrhines 
lack a functional a1 ,3GT enzyme was forestalled by the shortage of information on the catarrhine GGTA 1 
coding region. The initial information was limited to partial sequences and chromosomal locations of an 
unprocessed human pseudogene and a processed (i.e., intronless) human pseudogene (23, ~~FI i.e., an 
orthologue and a paralogue of GGTA1. Based on the finding that the unprocessed pseudogene sequence 
shared the same in-frame termination codon with the processed pseudogene sequence, it was assumed 
that the processed pseudogene was generated from an already inactivated source gene (8, 23.). It was 
further assumed from partial catarrhine sequences (25) that the GGTA 1 locus became an unprocessed 
pseudogene twice, once in apes and separately in Old World monkeys. Because the aGal epitope or 
antigenically similar epitopes occur widely among the different forms of life, including pathogens, it has 
been suggested that the primary reason for why the catarrhines would lose aGal is that there would be an 
immunological advantage afforded by anti-aGal antibodies m, 23, 25-27). There might also be enhanced 
defense against those pathogens that have binding sites for aGal epitopes, because these pathogens 
might then not be able to attach themselves to the aGal-negative cells of catarrhines. 
The molecular basis for the absence of aGal epitope expression in catarrhine primates was definitively 
elucidated by delineation of the full coding region and exon-intron structure of the unprocessed 
pseudogene (termed UPG) in rhesus, orangutan, and human genomes (28). In contrast to the hypothesis 
of independent inactivation in apes and Old World monkeys, the presence of two shared derived 
substitutions in the UPG of the three catarrhine species indicated that GGTA 1 inactivation occurred in the 
stem lineage of catarrhines EO~FK Sequence comparisons also indicated that the origin of the processed 
pseudogene (GGTA 1 P, termed PPG) preceded the origin of UPG, in contradiction to the previous view that 
the PPG arose from the UPG (a, 23). 
The uncertainty as to PPG's origin has been resolved by the finding in this study that the PPG locus is 
present in both platyrrhines and catarrhines but not in the prosimians that are strepsirrhine primates. We 
identified the expressed GGTA 1 locus and sequenced cDNA representing this locus in two strepsirrhines 
(lemur and loris) and partially sequenced such cDNA in the haplorhine prosimian (tarsier). With a data set 
of GGTA 1, UPG, and PPG orthologues and paralogues, we reconstructed the evolutionary history of these 
sequences, dating not only when the PPG arose in the stem anthropoids but also when the active gene 
became a pseudogene, i.e., UPG, in the stem catarrhines. Our data contradict the view that the active 
gene was relatively neutral to natural selection. Instead, our data suggest that purifying selection pressure 
favored retention of the GGTA 1 gene in noncatarrhine mammals even though they then lacked the 
possible immunological advantage that would be afforded by producing anti-aGal antibodies. Furthermore, 
we infer that pseudogenization of the functional GGTA 1 gene in catarrhines became possible only after 
alternative and/or more beneficial glycosyltransferase activity evolved in the stem lineage of the catarrhine 
primates. 
RESULTS 
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Alignment File. 
In this study, full coding region GGTA 1 sequences were generated from lemur, loris, and howler monkey 
samples, and PPG sequences were generated from capuchin, marmoset, rhesus, orangutan, and 
chimpanzee samples. Also, a partial coding region sequence from a putative GGTA 1 locus was generated 
from a tarsier sample. These sequences and previously reported sequences for the active GGTA 1 gene 
and the PPG and UPG homologues [see supporting information (SI) Table 2] were aligned for subsequent 
phylogenetic analyses. An alignment file containing the full set of GGTA1, UPG, and PPG nucleotide 
sequences referred to in this study is available in Nexus format as SI Data Set 1. The species with the 
active 01 ,3GT enzyme show many conserved amino acid residues, among which are the 16 that have 
been previously described as required for the enzyme to function properly (29-32). These 16 residues are 
identical in all species with an active GGTA 1 coding region except in the howler monkey, which differed at 
three of the critical residues: S207C, R210S, and H288Y (numbered according to the marmoset amino acid 
sequence). The species with an inactivated GGTA 1 coding region, Le., all catarrhine UPG sequences, 
show in the alignment file a single nucleotide position gap located where the marmoset sequence codes for 
amino acid residue 81. This gap designates a frame shift deletion just 5' of the coding sequence region 
specifying the enzyme's catalytic domain (2m. Thus, if any transcribed message with this frame shift 
deletion had been translated in the stem catarrhines, the resulting polypeptide would not have been 
functional. 
Nonsynonymous to Synonymous Rates (w). 
Phylogenetic Analysis by Maximum Likelihood (PAML) (33) rejected the hypothesis (X2 = 116.44,37 df, P 
< 0.0001) of a molecular clock under the "one-ratio" MO model (-In L = 7014.74) with a single w [Le., 
nonsynonymous substitutions per nonsynonymous site (dN)/synonymous substitutions per synonymous 
site (dS)] value on all branches in favor of a ''free ratio" M1 model (-In L = 6956.52) that allowed the w 
value to vary on every branch. The M1 tree is depicted in BgJ. In general, the w values are well below 1 
for all lineages in which GGTA 1 was active. This pattern of purifying selection is consistent with the 
hypothesis that GGTA 1 is a functionally important gene. The highest w values for active lineages are on 
the lineage leading to the howler monkey and on the stem primate lineage. The w values for the UPG and 
PPG are much more compatible with neutrally evolving lineages, with w values that tend toward a value of 
1. Branch test results comparing the MO (-lnL = 4766.92) and M2 (-Inl = 4764.96) models for the active 
gene data set were significantly different (X2 = 3.93, 1 df, P < 0.05), with the howler lineage showing a 
dN/dS ratio more than two times higher than the ratio estimated for the rest of the tree (0.64 vs. 0.28, 
respectively). Maximum parsimony (MP) and maximum likelihood {ML)-reconstructed ancestral sequences 
yielded dN/dS ratios that were similar to those obtained by PAML analysis except that the primate stem 
showed a lower ratio (0.36 and 0.20 for MP and ML, respectively) (data not shown), indicative of an active 
gene evolving under strong purifying selection. 
Fig. 1. 
PAML-estimated w (Le., dN/dS) and (N*dN, S*dS) values under the M1 ''free ratio" model, which allows the w value to 
vary on each branch. Estimated number of nonsynonymous and synonymous sites under this model are 827.4 
(more ... ) 
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rhe optimal MP, ML, and Bayesian phylogenetic results are in close agreement (Eig,J). Parsimony searches 
'ecovered three most parsimonious trees of length 1,121, and the only source of incongruence among these 
opologies is the branching order of the GGTA 1 sequences within the New World monkey clade. The optimal 
VlL topology agrees with both the MP and Bayesian topologies. Branch support for all clades (SI Table 3) is 
Jenerally quite high. 
rime of PPG and UPG Origin. 
rhe PPG lineage is estimated to have originated 57.6 mya, indicating an appearance on the stem anthropoid 
ineage at a date close to that of the tarsier-anthropoid last common ancestor (LCA): i.e., the crown haplorhinl 
_CA. The UPG lineage is estimated to have originated 28.1 mya, supporting the inference that the conversior 
)f the GGTA 1 to the UPG locus preceded the crown catarrhine LCA by only a few million years. 
rarsier Sequence. 
rhis study also provides sequence information from the genus Tarsius for its putative GGTA 1 locus. It is not 
~ertain whether the sequences obtained represent PPG or GGTA 1 sequences. In favor of the former, 
)hylogenetic analyses group the tarsier sequences with sequences from the PPG clade, albeit with low branc 
)Upport (SI Table 4:). This finding is consistent with the calculated appearance of the PPG at a time close to 
he haplorhine LCA (see above). Conversely, there are no disruptive mutations in the sequence that would 
~ause either reading frameshifts or premature termination codons. Also, in the phylogenetic tree that included 
he partial tarsier sequence, the tarsier lineage has a low w value (0.21, SI Fig. 3), which indicates a functionc 
Jene under purifying selection. It will be necessary to obtain either intronic or full-length cDNA sequence data 
o fully determine whether the tarsier possesses an active GGTA 1 locus. 
::volutionary Rates. 
rhe "Hominoid Slowdown" hypothesis was originally proposed on the basis of data that revealed very small 
jegrees of serum albumin antigenic divergence among hominoids (apes, including humans) and also on the 
Jasis of ideas concerning such hominoid organismal features as lengthened gestations and increased 
Jeneration times (34-3Q). That a slowdown in rates of molecular evolution occurred has been affirmed in 
lumerous studies since then E~T-~OFK A comparison of rates calculated from the PPG clade supports the 
~oncept of a rate slowdown in anthropoid lineages, especially in the catarrhines (Table 1). The UPG rates alsl 
,how the hominoid rate being slower than the Old World monkey rate. 
Table 1. 
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DISCUSSION 
=rom our results, we can infer that, in noncatarrhine mammals, the GGTA 1 gene functions under strong 
)hysiological constraints. The reconstructed evolutionary history of this gene (Fig. 2) reveals that, in the stem 
ineage to anthropoid primates, near the time of the tarsier-anthropoid LeA (::::57-58 mya), GGTA 1 gave rise 
o a processed, retrotranscribed pseudogene. The two paralogously related loci (GGTA 1 and PPG) then 
~oexisted in the same anthropoid lineages but evolved independently of each other. The retrotranscribed PPC 
ocus freely accumulated mutations that escaped the scrutiny of natural selection, whereas the parent GGTA i 
Jene did not escape such scrutiny in the anthropoid stem and platyrrhine lineages but, nevertheless, did 
)ecome a UPG in the late catarrhine stem lineage (::::28 mya). Thereafter, the UPG sequences accumulated 
nutations freely in catarrhine lineages. 
~-----K ~ Fig. 2 . 
..... -;:;.;:'_. Phylogeny of the GGTA 1 locus. Shown in black are the lineages in which GGTA 1 remained active. Shown in red are 
the lineages in which GGTA 1 was inactivated. Blue and red arrows indicate, respectively, the origin of the processed 
pseudogene (PPG) and the (more ... ) 
)espite being freed of physiological constraints, both the PPG and UPG sequences have nucleotide 
,ubstitution rates that slowed in hominoid lineages. This slowdown indicates that rates of occurrence of new 
nutations decreased during the descent of hominoids. In turn, the decreased de novo mutation rates probabl~ 
'esulted directly from lengthened generation times and indirectly from the whole suite of adaptive changes the 
,haped catarrhine origins and evolution. We suspect that among the adaptive changes were those that 
)rought about a new pattern of sugar chain expression that then permitted inactivation of the GGTA 1 gene. 
f the production of anti-oGal antibodies was the crucial survival advantage worth loss of the 01 ,3GT enzyme, 
nactivation of the GGTA1 gene should have occurred in many mammalian species. Yet over the past 100 or 
,0 million years, no examples of oGal-negative lineages are known to have arisen among noncatarrhine 
nammals (la-ZQ, 28, 4~I and this study). Indeed, strong purifying selection with preservation of the functiona 
'3GTA 1 locus in noncatarrhine mammals is evident from our finding that the oGal-positive lineages 
lCcumulated nonsynonymous substitutions at this locus much more slowly than synonymous substitutions 
ElsL1J· 
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That loss of the GGTA 1 gene can be deleterious has become evident by the production of GGTA 1 KO 
mice and pigs for xenotransplantation research (21, 22, 44). Animals with GGTA 1 KO have both subtle and 
conspicuous health abnormalities. For example, the KO mice develop early-onset cataracts (21). The 
founder KO pigs were only a few months old and appeared to be healthy at the time they were reported 
(22). However, they proved to be small, frail, and difficult to breed (unpublished observations of C.K., M.T., 
and T.E.S., who also are coauthors of ref. 22). Such findings are consistent with the view that the GGTA 1 
gene plays an important role in the endogenous metabolic homeostasis of aGal-positive species. 
However, the fact that the KO is not lethal suggests that the activities of the a1 ,3GT enzyme can be 
substituted for (albeit incompletely) by another glycosyltransferase or by multiple glycosyltransferases. We 
propose that adaptive coevolution of other glycosyltransferase genes made such a substitution possible in 
the late stem-catarrhines. If the functional consequences of the replacement glycosyltransferase activity 
were more beneficial than the original a1 ,3GT activity, that could have provided the major impetus for 
GGTA 1 gene inactivation. However, the inactivation would still leave open the possibility that pathogen 
resistance played a substantial role in GGTA 1 evolution. 
No doubt, the evolution of glycosyltransferase gene families (26, 4S-48) involved not only changes in 
enzyme encoding sequences but also in promoter and other regulatory sequences. Such changes would 
be expected to result in species-specific patterns of developmental and tissue expression. For example, 
the ASH epitopes are expressed in the digestive mucosa of all mammalian species but are not expressed 
on the vascular endothelial cells (VEC) of noncatarrhine mammals (49). All catarrhines express ASH 
epitopes on VEC. Apes also express ASH epitopes on RSC but Old World monkeys do not (49). Another 
example of species differences in oligosaccharide tissue expression patterns involves the sialic acid 
moiety. This moiety is found at higher concentrations in the brains of apes than in other mammals and, 
among apes, is more abundant in human than in chimpanzee brains (SO). A striking finding is the loss of 
the sialic acid moiety N-glycolylneuraminic acid (NeuSGc) in humans and its replacement by a greater 
abundance of its precursor, N-acetylneuraminic acid (NeuSAc) (S1). This human-specific loss resulted from 
an inactivating mutation in the gene encoding cytidine-monophosphate N-acetylneuraminic acid 
hydroxylase (CMAH) (S1). Siglecs, i.e., receptors that can interact with the cell-surface sialic acid 
oligosaccharides, also show striking evolutionary changes in descent of catarrhine lineages (S1, S2). 
Clearly, the changes associated first with catarrhine primate emergence and then with later ape lineages 
involved striking shifts in the expression of sugar chains. The evidence from our study indicates that 
maintenance of the GGTA 1 gene was an obligatory condition for survival of noncatarrhine mammals in the 
wild. In our metabolic hypothesis, the aGal-negative state could not be established until the activity of the 
a1 ,3GT enzyme was replaced by alternative and/or more beneficial glycosyltransferase activity, i.e., by a 
major adaptive change in sugar chain metabolism. The resulting production of anti-aGal antibodies may 
well have enhanced protection against aGal-positive pathogens (26, 27), but this added benefit from the 
loss of aGal would have required first the alterations in sugar-chain metabolism. 
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Loss of oGal in the late stem-catarrhines may have been implicated in the decreased reliance on olfaction 
that accompanied the greater reliance on vision. Observations made on the sensory epithelium of the 
vomeronasal organ (VNO) of rats (10) show that oGal epitopes are abundantly expressed in this sensory 
epithelium and thus presumably engaged in the VNOs important olfactory function of detecting 
pheromones. Catarrhines have atrophic VNO tissue, loss of olfactory receptor genes, and decreased 
pheromone detection abilities E~I 93, 54). It may be significant that the only noncatarrhine lineage in our 
GGTA 1 analysis showing an increased dN/dS ratio is the platyrrhine lineage to the howler monkey, 
suggesting that purifying selection for maintenance of 01 ,3GT function acted less strongly on this lineage 
than on all other noncatarrhine lineages. Possibly, the howler monkey relies less on olfaction than on vision 
as suggested by Gilad et al. (54). The howler monkey is the only primate other than catarrhines that is 
known to have full trichromatic vision E~I 95-58). Examination of many other primates, especially other 
members of the Atelidae (the family to which howler monkeys belong) is needed to determine whether, 
among noncatarrhine primates, the decreased purifying selection acting on the GGTA 1 gene is specific to 
the howler monkey. 
Finally, however, we emphasize that studies of the GGTA 1 gene cannot be interpreted in isolation. Since 
discovery of the ABO (H) histo-blood groups, such systems have been seen mainly 'from the perspective of 
immunological reactions to cell-surface antigens (26, 45, 46). In place of the hypothesis that loss of oGal 
was primarily driven by an immunologic advantage against pathogens, we propose that GGTA 1 
inactivation could not be established until alternative glycosyltransferase activity replaced 01 ,3GT activity. 
This replacement involved striking shifts in sugar-chain expression patterns. In subjecting the many 
glycosyltransferase genes to detailed phylogenetic studies, the species chosen should reflect the great 
adaptive diversity that exists among primates and other mammals. The results of such studies should help 
test our hypothesis that positively selected changes in sugar chain metabolism coincided with and helped 
bring about emergence and evolution of the catarrhine primates. 
MATERIALS AND METHODS 
Materials. 
Whole blood from the ring-tailed lemur (Lemur catta) , slender loris (Loris tardigradus), Philippine tarsier 
(Tarsier syrichta) , common marmoset (Callithrixjacchus), white-throated capuchin (Cebus capucinus) , 
black-and-gold howler (Alouatta caraya), rhesus macaque (Macaca mulatta), orangutan (Pongo 
pygmaeus), and chimpanzee (Pan troglodytes) was kindly provided by the Pittsburgh Zoo (Pittsburgh, PA), 
University of Wisconsin (Madison, WI), University of Pittsburgh, Wayne State University, Yerkes National 
Primate Research Center Emory University (Atlanta, GA), or the Duke University Primate Research Center 
(Durham, NC). 
Methods. 
Standard methods were used to isolate high-molecular-weight genomic DNA from the various samples. 
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Total RNA was extracted from the samples with TRlzol reagent (GIBCO, Carlsbad, CA). Poly(A)+ RNA was 
separated from total RNA by using the Dynabeads mRNA Purification Kit (Dynal, Oslo, Norway) according 
to the manufacturer's instructions. 
DNA Amplification and Sequencing. 
GenomeWalker libraries for the respective species were constructed by using the Universal 
GenomeWalker Library kit (Clontech, Palo Alto, CA). Human PPG amplification was obtained with 
GenomeWalker-PCR. Species- or clade-specific PPG primers were designed from sequences initially 
obtained by using the human PPG primer set. For the lemur GGTA 1 gene, primers were designed based 
on sequence obtained by using the previously published (28) human UPG primer set; these newly 
designed primers were also used to obtain loris and tarsier gene sequences. Primer sequences used to 
identify the various genes are as follows: Lemur GGTA 1 gene: L9A, 5'-
CATCATGCTGGACGACATCTCCAAGATGC-3'; L9B, 5' -CAAGCCTGAGAAGAGGTGGCAGGACATC-3'; 
L9P, 5' -GT ATGCTGACTTT ACGCCTCTCAT AGG-3'; L9Q, 5' -GTAGCTGAGCCACTGACTGGCCCAG-3'. 
New World monkey PPG: M4a, 5'-AGGAGAAAATAATGAATGTCAAAGGAAACGT-3'; M6a, 5'-
ACACCCAGAAGTTGTTGACAGCGGCAC-3'; M8p, 5'-TCTTTCCACAGCAAACCCATCAACCCCA-3'; M8q, 
5'-GCCTTCCCACATAACCGGCACATTCCA-3'. Rhesus PPG: Rpa, 5'-
GCTGAGTGGATGGATGATGGGGAGGAG-3'; Rpq, 5'-CAAGCTGATCTCGAACTCCTGACCTCACGTG-
3'. Orangutan PPG: Upa, 5'-GTCAAAGCCGATACGTTTTCCCGGCAG-3'; Upq, 5'· 
ACCAT AGATTCATTCTCTCAT ATT ACAGTGCTC-3'. 
TaKaRa LA Taq (Takara Shuzo, Shiga, Japan) and Titanium Taq (Clontech) enzyme were used for all 
PCR experiments. The PCR thermal cycling conditions, recommended by the manufacturer, were 
performed on a Gene Amp System 9600 or 9700 thermocycler (PerkinElmer, Wellesley, MA). 
To identify the 5' and 3' ends of the GGTA 1 gene or UPG transcripts of the lemur, loris, tarsier, marmoset, 
capuchin, rhesus, orangutan, and chimpanzee, the Marathon RACE (rapid amplification of cDNA end) 
libraries (Clontech) were constructed from total RNA of the different species in accordance with the 
manufacturer's specified protocol. 
PCR products amplified by the GW·PCR, RACE·PCR, and RT-PCR were subcloned into the pCR II vector 
provided with the Original TA Cloning kit (Invitrogen, Carlsbad, CA). Automated fluorescent sequencing of 
cloned inserts was performed by using an ABI 377 DNA Sequence Analyzer (Applied Biosystems, Foster 
City, CA). 
Sequence Analyses. 
Newly obtained and previously reported DNA sequences (81 Table 2) were manually aligned in MacClade 
4.08 (59). Deduced amino acid sequences of GGTA 1 genes were checked for accuracy against protein 
sequences associated with the nucleotide GenBank accession numbers. Gene trees were inferred by 
using MP and ML methods as implemented in PAUP* 4.0b10 (60) and by using Bayesian methods as 
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implemented by MrBayes 3.1 (61). For the latter two methods, the optimal model of sequence evolution 
was determined by using ModelTest 3.7 (62) and MrModeltest2.2 (63), respectively, before inferring 
optimal gene trees. ModelTest 3.7 selected TVM+r as the best-Jit model (-lnL = 7125.71) according to the 
Akaike Information Criterion (Ale) (64), with the following associated parameters: Lset Base = (0.2876 
0.21170.2446), Nst = 6, Rmat = (1.7559 5.6656 0.73551.74485.6656), Rates = y, Shape = 1.1091, 
Pinvar = O. MrModelTest2.2 selected a GTR+ r as the best-fit model according to the AIC, with the 
following model form: Prset statefreqpr = dirichlet (1,1, 1,1); Lset nst = 6 rates = y. 
Patterns of selection across the inferred tree for the entire data set were estimated by using PAML 3.15 
(33). In addition, ancestral sequences were reconstructed by using MP (with the DELTRAN algorithm) and 
ML (by using the TVM+r model) methods for each node in the tree depicted in fuLl; dN/dS for each node 
and its descendent branch was then calculated by using MEGA 3.1 (65) with the Pamilo-Bianchi-Li 
method (QQ, 67). The existence of a molecular clock was tested by comparing the MO model, which 
estimates a single w (dN/dS) ratio for all links contained in the tree, with the M1 model, which is allowed to 
estimate a different w ratio for each link contained in the tree. In addition, to test whether the appearance 
of color vision correlates with a pattern of selection that suggests a reduction of functional constraints, a 
data set containing only the active genes was analyzed by comparing the MO model with an M2 model, 
which allowed one rate for the howler lineage and another for the rest of the tree. In all cases, the 
existence of multiple local optima was evaluated by running each model three times, with three different 
staring w values (0.5, 1, and 2). Where differences existed, the value with the highest likelihood score was 
used to compare models by using the likelihood ratio test. 
Estimating the Time of PPG and UPG Origin. 
The origin of the PPG and UPG sequences was estimated by using both the topology determined by the 
gene tree analyses and the nonsynonymous (N) and synonymous (S) values depicted in Bg--1. As in 
Goodman et al. (Q), Goodman (68), and Wildman and Goodman (69),63 my a was taken as the date for the 
LCA of the living primates, 40 my a for the LeA of living anthropoids (platyrrhines and catarrhines), 26 my a 
for the LeA of living platyrrhines, 25 my a for the LeA of living catarrhines, and 14 my a for the orangutan-
human LeA. 
PPG Origin. 
By using the Nand S changes determined for each lineage depicted in EjgJ, the distance (number of N 
plus number of S) between the primate LeA and the PPG-stem anthropoid LeA added to the distance 
between PPG-stem anthropoid LeA and crown anthropoid LeA was equated to 23 million years (63-40 
mya); this value totaled 41.5. Then, by proportionality, the number of million years (X) was determined 
between: (/) primate LeA and PPG-stem anthropoid LCA; 23 million years/41.5 = Xl9.8, where X = 5.4 
million years, indicating a time of PPG origin at (63-5.4) or 57.6 mya. (iJ) PPG-stem anthropoid LCA and 
crown anthropoid LeA; 23 million years/41 .5 = X/31.7, where X = 17.6 million years, indicating a time of 
UPG origin at (40 + 17.6) or 57.6 million years. 
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UPG Origin. 
Next, the conversion of the ACT to UPG on the catarrhine stem was determined by assuming that, at the 
time of pseudogenization, a slow rate for N functional substitutions became a fast rate for N pseudogene 
substitutions. By using the N changes depicted in b~1K a functional N rate was estimated from the 
platyrrhine stem (e.g., 3.5/14 = 0.25 N per million years) and a pseudogene N rate was estimated from the 
UPG branch to the rhesus monkey (e.g., 37.1/25 = 1.48 N per million years). With these two rates and the 
total number of N changes on the 15 million years represented by the catarrhine stem (i.e., 7.6), the 
number of millions of years that the stem catarrhine GGTA 1 locus existed before it became the UPG locus 
(i.e., X) was calculated in the following manner: 0.25X + 1.48 (15 - X) = 7.6. Thus, X = 11.87 million years, 
and the UPG locus originated :::::28.1 mya. 
Finally, overall evolutionary rates were calculated for selectively neutral DNA as represented by the PPG 
clade and for PPG and UPG rates from the crown catarrhine LCA until the present day. 
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UPG unprocessed pseudogene. 
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